Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Creo Medical Group Plc
Change of Nominated Adviser and Joint Broker
Published Oct 16 2023
3 min read

Change of Nominated Adviser and Joint Broker

 

Creo Medical Group plc

("Creo" the "Company" or the "Group")

 

Change of Nominated Adviser and Joint Broker

 

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

 

Enquiries:

 

Creo Medical Group plc

www.creomedical.com

Richard Rees (CFO)

+44 (0)1291 606 005



Cavendish Capital Markets Limited

+44 (0)20 7397 8900

Stephen Keys / Camilla Hume (NOMAD)


Michael Johnson (Sales)




Numis Securities Limited (Joint Broker)

+44 (0)20 7260 1000

Freddie Barnfield / Duncan Monteith / Euan Brown




Walbrook PR Ltd

Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com

Paul McManus / Sam Allen 

Phillip Marriage 

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

+44 (0)7867 984 082